What State Board of Pharmacy Inspections Actually Check
Every compounding pharmacy in the United States is subject to inspection by the state board of pharmacy where it holds a license. These inspections are not optional — they are a condition of licensure. And what inspectors look for reveals a lot about what can go wrong when compounding quality slips.
If you're using a compounded GLP-1, your medication was prepared in a pharmacy that has been (or will be) inspected by state regulators. Understanding what those inspectors check helps you evaluate the pharmacy's compliance record — and ask smarter questions about the quality of what you're injecting.
Types of Inspections
Routine Inspections
Most state boards conduct routine inspections on a scheduled cycle — typically every one to three years, depending on the state and the pharmacy's risk profile. Sterile compounding pharmacies are generally inspected more frequently than standard dispensing pharmacies because the products they prepare carry higher patient safety risks.
For-Cause Inspections
These are triggered by complaints, adverse event reports, or referrals from other agencies (including the FDA). A for-cause inspection can happen at any time, without advance notice, and typically focuses on the specific concern that prompted it — though inspectors may expand scope if they identify additional problems.
Pre-Licensure Inspections
Before a pharmacy receives its initial compounding license or adds sterile compounding to its capabilities, most states require a pre-licensure inspection to verify that the facility, equipment, and personnel meet requirements before any compounding begins.
What Inspectors Look For
Facility and Equipment
- Cleanroom design matches the required ISO classifications (ISO 5 PEC within ISO 7 buffer room, ISO 8 anteroom)
- HEPA filters are certified and within their certification period (typically annual re-certification)
- Air pressure differentials between rooms are correct (positive pressure in cleaner areas to prevent contamination flow from dirtier areas)
- Equipment is calibrated and maintained on documented schedules (balances, refrigerators, temperature monitoring systems)
- Proper segregation of hazardous and non-hazardous compounding areas
Documentation and Records
- Master formulation records exist for every compounded preparation
- Compounding records document each batch: who compounded it, what lots were used, what checks were performed
- Environmental monitoring results are recorded, trended, and acted upon
- Personnel training and competency records are current
- Temperature logs for refrigerators, freezers, and cleanrooms are maintained continuously
- Standard operating procedures (SOPs) exist and are being followed
Personnel Practices
- Garbing procedures are followed correctly (inspectors may observe the gowning process)
- Aseptic technique is demonstrated during compounding operations
- Media fill test results are current for all compounding personnel
- Gloved fingertip sampling results are documented and within action levels
Product Quality
- Beyond-use dates are assigned correctly and supported by appropriate data
- Finished product testing (sterility, endotoxin, potency) is performed where required
- Ingredients are sourced from legitimate, FDA-registered suppliers with proper documentation
- Returned, recalled, or expired products are segregated and handled properly
A pharmacy with no deficiency citations over multiple inspection cycles is demonstrating consistent compliance — not just point-in-time readiness. This is a strong quality signal that's harder to fake than marketing claims.
Common Deficiency Findings
State board inspection reports are public records in most states. The most common deficiency findings in compounding pharmacy inspections include:
- Incomplete or missing documentation: Missing compounding records, unsigned SOPs, or gaps in temperature logs. This is the most common category of findings and often indicates systemic quality management weaknesses rather than isolated oversights.
- Environmental monitoring gaps: Sampling not performed at required frequency, results not trended, or action levels exceeded without documented investigation and corrective action.
- Facility maintenance issues: HEPA filter certification lapsed, air pressure differentials not meeting specifications, or cleanroom surfaces showing wear or damage.
- Personnel training deficiencies: Media fill tests expired, initial competency assessments incomplete, or lack of annual re-evaluation documentation.
- Beyond-use dating without support: BUDs assigned beyond USP defaults without the required stability data to justify the extension.
How to Check Your Pharmacy's Inspection Record
Most state boards of pharmacy maintain public databases where you can look up a pharmacy's license status, inspection history, and any disciplinary actions. The process varies by state:
- State board websites: Search for "[state name] board of pharmacy license verification" — most have an online lookup tool where you can enter the pharmacy name or license number.
- NABP: The National Association of Boards of Pharmacy operates a multi-state database and accreditation programs (including VAWD — Verified Accredited Drug Distributor) that cross-reference pharmacy standing across jurisdictions.
- Public records requests: If inspection reports are not available online, most states allow public records requests for inspection findings. Some states charge a nominal fee.
Multi-State Licensing
Many compounding pharmacies that serve telehealth patients are licensed in multiple states — the state where the pharmacy is physically located, plus each state where they ship compounded prescriptions. This means they may be inspected by multiple state boards, each applying its own interpretation of USP standards. A pharmacy with clean inspection records across several states demonstrates consistent quality practices, not just compliance with one state's particular requirements.
Providers That Emphasize Pharmacy Compliance
Embody
Injectable semaglutide through established 503A pharmacy partnerships. Clinician-monitored dosing with direct pharmacy fulfillment.
Compounded medications are not FDA-approved.
Learn More Paid linkFound Health
Clinically-guided weight loss with GLP-1 options, behavior coaching, and metabolic tracking built in.
Compounded medications are not FDA-approved.
Learn More Paid linkOak Health
GLP-1 weight loss program with pharmacy-direct fulfillment and provider consultations included.
Compounded medications are not FDA-approved.
Learn More Paid linkCompare GLP-1 Providers Side by Side
See pricing, pharmacy credentials, and delivery formats for verified telehealth providers.
View Provider Comparison →Sources
- NABP. "Guidelines for State Board of Pharmacy Compounding Inspections." 2024.
- USP. "General Chapter <797> Pharmaceutical Compounding — Sterile Preparations." Revised November 2023.
- FDA. "Inspections of Compounding Facilities." Compliance Program Guidance Manual, Chapter 29.
- Pharmacy Times. "State Boards of Pharmacy Intensify Compounding Oversight in Wake of Federal Regulatory Changes." 2025.
Affiliate Disclosure: Some links on this page are paid affiliate links. If you sign up through them, we may earn a commission at no extra cost to you. This does not influence our editorial content or provider evaluations.
Medical Disclaimer: This content is for informational purposes only and is not medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
FDA Notice: Compounded medications referenced in this article are not FDA-approved. Only brand-name GLP-1 medications (Wegovy, Zepbound, Ozempic, Mounjaro) carry FDA approval for their indicated uses.